Clinical Trials Logo

Filter by:
NCT ID: NCT05540262 Recruiting - Optic Neuritis Clinical Trials

Edaravone in the Treatment of Aquaporin-4 Antibody-positive Optic Neuritis

Start date: January 15, 2022
Phase: N/A
Study type: Interventional

Edaravone has demonstrated a beneficial effect in promoting remyelination and protecting axons in animals with NMOSD. The researchers posit that edaravone may enhance visual outcomes in patients with aquaporin-4 antibody-positive optic neuritis.

NCT ID: NCT05539859 Recruiting - Clinical trials for Intracerebral Hemorrhage Basal Ganglia

Efficacy and Safety of NeuroEndoscopic Surgery for IntraCerebral Hemorrhage

NESICH
Start date: November 18, 2022
Phase: N/A
Study type: Interventional

To compare the efficacy and safety of neuroendoscopic hematoma removal and standard conservative treatment for patients with spontaneous supratentorial deep intracerebral hemorrhage.

NCT ID: NCT05539833 Recruiting - Clinical trials for Refractory Solid Tumors

KSH01-TCRT Solid Tumors

KSH01-TCRT
Start date: August 19, 2022
Phase: Early Phase 1
Study type: Interventional

1) Safety and efficacy of TCR-T cells in subjects with refractory/relapsed solid tumors. 2) The activation and proliferation of TCR-T cells in the subject, and the survival time.

NCT ID: NCT05539781 Recruiting - Clinical trials for Cardiovascular Diseases

Change of Hemodynamics and Cerebral Functions After Carotid Artery Revascularization

HALO
Start date: January 1, 2020
Phase:
Study type: Observational

The majority (>80%) of strokes are of ischemic etiology, of which ≈15% to 20% are attributable to atherosclerosis of the extracranial carotid arteries. The primary goal in carotid artery revascularization is to prevent stroke in patients with carotid artery stenosis. Treatment options including carotid endarterectomy (CEA) and carotid artery stenting (CAS). Hence, the investigators aim to compare carotid artery stenting (CAS) with carotid endarterectomy (CEA) in terms of long-term prognostic endpoints. Also, CEA and CAS result in different postoperative geometric features of carotid arteries that entail relevant modifications of rheological parameters, that may be associated with the risk of local complications and carotid artery restenosis. Finally, long-term and sustained cognitive benefits after carotid artery revascularization need further research and evidence.

NCT ID: NCT05539521 Recruiting - Critically Ill Clinical Trials

Efficacy and Safety of Remimazolam Besylate Versus Propofol for Sedation in Critically Ill Patients With Deep Sedation

Start date: September 5, 2022
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of remimazolam besylate compared to propofol for sedation in critically ill patients with deep sedation.

NCT ID: NCT05539248 Recruiting - Hemolysis Clinical Trials

A Study on the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of CAN106 in Subjects With PNH

Start date: March 25, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of the study is to evaluate the safety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of CAN106 administered intravenously to subjects with PNH who have not previously been treated with a complement inhibitor.

NCT ID: NCT05539105 Recruiting - Reconstruction Clinical Trials

A Prospective Observation Registry Study on the Alimentary Reconstruction After Radical Proximal Gastrectomy

STAR-PG01
Start date: August 22, 2022
Phase:
Study type: Observational [Patient Registry]

This study is designed as a prospective, real world registry study that compare the safety and efficacy of the different construction methods after radical proximal gastrectomy.

NCT ID: NCT05539001 Recruiting - Clinical trials for Systemic Lupus Erythematosus

Screening Biomarkers for Severe Lupus Based on Multi-omics Studies

Start date: February 1, 2023
Phase:
Study type: Observational [Patient Registry]

In order to achieve accurate diagnosis and treatment of the disease, we performed RNA sequencing and ATAC(Assay for Transposase Accessible Chromatin) chromatin open sequencing in lupus patients in the early stage. By comparing with normal controls, other rheumatic immune diseases (rheumatoid arthritis), and before and after treatment, dozens of disease-causing genes independently associated with the disease were identified. Based on the previous omics results, this project will analyze its changes in different outcomes of lupus patients, and use machine learning methods to establish an optimal severe prediction model, so as to build an early diagnosis system based on novel biomarkers and reduce all-cause mortality in patients with treatment failure rate. It is expected to produce good social and economic benefits.

NCT ID: NCT05538676 Recruiting - Solid Tumor, Adult Clinical Trials

Fluoride-labeled Boronophenylalanine PET Imaging in Patients With Solid Tumors

Start date: December 26, 2022
Phase:
Study type: Observational

Recently, new high-dose radiation therapy [e.g., boron neutron capture therapy (BNCT)] absorbed into the tumor tissue has been applied to treat patients with solid tumors. Here we examine and describe how to evaluate the biological activity of tumors using positron emission tomography (PET) with fluoride-labeled boronophenylalanine (F-BPA) as a tracer.

NCT ID: NCT05538507 Recruiting - Alzheimer Disease Clinical Trials

Efficacy of Chinese Traditional Medicine "Smart Soup" in Cognition and Behavior Regulation in Alzheimer's Disease

Start date: June 1, 2022
Phase: Phase 2
Study type: Interventional

It is a prospective interventional randomized controlled single center trial. The goal of the trial is to evaluate the efficacy of smart soup on cognition, behavior, biomarkers and safety in Alzheimer's disease (aMCI and dementia).